Aubex Corporation, known for its high precision pen nib processes, has launched a medical division focused on advanced infusion technology.
AuBEX Corporation, a company with over 130 years of history, is making significant strides in the medical industry with its cutting-edge product, the VESSEL FUSER, a pressurized medicament injector. Initially renowned for its precision in pen nib manufacturing, AuBEX used its technical expertise to successfully develop advanced medical devices, which it began working on in the 1990’s and launched in 1996.
“By applying our pen-nib extrusion technology, we’ve been able to innovate in the medical field without being confined to our original domain,” says Norigi Kurihara, president of AuBEX. This adaptability has allowed the company to transition from producing high-precision pen nibs to creating sophisticated medical devices like the VESSEL FUSER.
VESSEL FUSER for labor analgesia
The VESSEL FUSER, which features a unique combination of a control tube and a flow rate switching device, is a standout product in its portfolio. Unlike similar devices, which offer only 3 to 7 levels of flow rate adjustment, the VESSEL FUSER boasts 12 levels, providing doctors with greater flexibility to manage pain for their patients. “This contributes to improving patients' quality of life by allowing more precise control over pain management,” Mr. Kurihara explains.
Since its launch, the VESSEL FUSER has become AuBEX's flagship product, initially used primarily for post-operative pain but now expanding into home healthcare and painless delivery applications. The device's portability and ease of use make it suitable for various healthcare settings, offering significant advantages over traditional mechanical infusion pumps.
Looking forward, Mr. Kurihara emphasizes the company’s commitment to innovation: “We aim to develop new medical products by utilizing our extrusion technology and fine flow control expertise.” With its strong foundation and focus on quality, AuBEX is poised to become a significant player in the global medical device market.
0 COMMENTS